Transgenic nmice with a A shuttle vector containing a lacI target gene were generated for use as a shortterm, in vivo mutagenesis assay. The gene is recovered from the treated mice by exposing mouse genomic DNA to in vitro packaging extracts and plating the rescued phage on agar plates containing 5-bromo-4-chloro-3-indolyl (3-D-galactopyranoside (X-Gal). Phage with mutations in the lacl gene form blue plaques, whereas phage with a nonmutated lacl form colorless plaques. Spontaneous background mutant rates using this system range from 0.6 x 10-S to 1.7 x i0-0, depending upon tissue analyzed, with germ cells exhibiting less than one-third the background rate of somatic tissue. Treatment of the mice
(X-Gal). Phage with mutations in the lacl gene form blue plaques, whereas phage with a nonmutated lacl form colorless plaques. Spontaneous background mutant rates using this system range from 0.6 x 10-S to 1.7 x i0-0, depending upon tissue analyzed, with germ cells exhibiting less than one-third the background rate of somatic tissue. Treatment of the mice with N-ethyl-N-nitrosourea (EtNU), benzo[alpyrene (B[a]P), or cyclophosphamide caused an induction of mutations over background. Recovery of the lacI target for sequence analysis was performed by genetic excision of a plasmid from the phage using partial filamentous phage origins. The predominant mutations identified from untreated and treated populations were base substitutions. Although it has been shown by others that 70% of all spontaneous mutations within the laI gene, when replicated in Escherichia cohi, occur at a hot spot located at bases 620-632, only 1 of 21 spontaneous mutations has been identified in this region in the transgenic mouse system. In addition, 5 of 9 spontaneous transitions analyzed occur at CpG dinucleotides, whereas no transition mutations were identified at the prokaryotic deamination hot spots occurring at dcm sites (CCA/TGG) within the WaI gene. For EtNU, approximately equal amounts of transitions and transversions were observed, contrasting with B[a]P-induced mutations, in which only transversions were obtained. In addition, B[a]P mutagenesis showed a predominance ofmutations (81 %) involving cytosines and/or guanines, consistent with its known mode of action. The discovery of a spontaneous mutation spectrum different from that of bacterial assays, coupled with the concordance of EtNU and B[a]P base mutations with the known mechanisms of activity for these mutagens, suggests that this transgenic system will be useful as a short-term, in vivo system for mutagen assessment and analysis of mechanisms leading to mutations.
The lacd gene has been used extensively as a target for the identification and analysis of spontaneous and induced mutations, due in part to the ease of using a calorimetric assay to rapidly screen for mutations. Genetic and sequence analysis of spontaneous and induced mutations detected in several systems utilizing lacd (1) (2) (3) (4) (5) has resulted in an extensive accumulation of data regarding the sequence specificity of spontaneous and induced mutations in lacd, which can be of considerable comparative value through the use of the lacd target gene in whole animal assay systems.
To combine the cost-saving aspects of short-term assays with the predictive power of whole animal assays, we previously described the development of a system that depends upon efficient recovery of a A phage shuttle vector from transgenic mouse genomic DNA through the use of restriction-negative Escherichia coli strains (6, 7) . This system has been used to observe dose-dependent induction of mutations over background levels using A shuttle vectors containing a lacZ target gene (6, 8) . We have extended our initial work on the lacZ A mutagenesis system by incorporating a lacd target gene into a A shuttle vector. The use of the lacd gene in this assay results in greatly simplified plaque detection (blue mutant plaques on a background of colorless nonmutant plaques) as well as allowing for higher phage plating densities (as much as 50,000 phage plaques per plate). In addition, the relatively small size of the target [1080 base pairs (bp) of coding region] facilitates sequence analysis and subsequent comparison to the large historical base of information available for lacd in several systems, allowing investigation of the underlying mechanisms leading to mutations.
Transgenic mice containing this A vector were exposed to three well-studied and representative mutagens. N-Ethyl-Nnitrosourea (EtNU) has been shown to be a strong directacting alkylating agent of DNA in eukaryotic and prokaryotic systems (9, 10) . Benzo[a]pyrene (B[a]P) is a member of an important class of environmental carcinogens, the polycyclic aromatic hydrocarbons, and has been shown to require metabolic activation resulting in the formation of a B[a]P diol-epoxide (BPDE) that covalently binds susceptible DNA targets (11) . Cyclophosphamide (CP) is a bifunctional alkylating agent that is used as a chemotherapeutic. CP, which also requires metabolic activation, has been identified as a human carcinogen (12) and a potent teratogen (13) . The two major cytotoxic metabolites of CP, acrolein and phosphoramide mustard, are alkylating agents of DNA and RNA (14) .
Described here are the effects of mutagenic exposure ofthe transgenic animals monitored by phenotypic alterations of the target lacI gene as well as sequence analysis of selected clones resulting from spontaneous and induced mutation of the target gene. Mutations identified here are then correlated with spontaneous and induced mutation data derived from existing whole animal and in vitro assays.
MATERIALS AND METHODS
A Shuttle Vector. The A vector used in these studies, A LIZa (lacIJ, lacZa) ( Fig. 1 filamentous phage origin. The positioning of the halves of the fl origin allows a plasmid containing the target gene to be excised from the surrounding A arms by superinfection with helper phage (16) , allowing rapid subcloning for sequence characterization of identified lacI mutants.
Purification of Genomic DNA from Tissues. Genomic DNA was prepared from somatic tissues as described (6, 17) . Isolation of seminiferous tubules containing germ cells was done by decapsulating testes followed by collagenase digestion (type II, Sigma) to release the tubules. The tubules were washed two times in phosphate-buffered saline and then incubated in a lysis buffer (0.2 mg of proteinase K per ml/2% 2-mercaptoethanol/10 mM Tris HCI, pH 8.0/100 mM NaCl/10 mM EDTA/0.5% SDS) for 3 hr at 50TC. Subsequent DNA isolation procedures were performed as described (6, 17) . This purification results in a genomic DNA sample containing -95% germ-cell DNA (18) .
Mutagenesis Assay. The entire assay procedure using the lacZ gene as the mutagenic target has been described in detail (6, 17) . The shuttle vector was recovered from genomic DNA by mixing with restriction-negative, p-galactosidase-negative in vitro A packaging extract (Transpack, SCS). The packaged phage were then preadsorbed to E. coli SCS-8 [recAl, endAl, mcrA, A(mcrBC-hsdRMS-mrr), A(argF-lac)U169, 480dlacZAM15, TnOO (tetr)], mixed with top agar containing 2 mg of 5-bromo4-chloro-3-indolyl j-D-galactopyranoside (X-Gal; SCS) per ml oftop agar, and poured onto assay dishes containing nutrient agar. Point mutations, deletions (<5 kb), and insertions (c8 kb) are detectable in the lacl promoter, lacI target gene, and/or the lacZ operator, which serves as the binding site for the lac repressor molecule ( Fig. 1 ; sizes for deletions and insertions are based upon A phage packaging constraints). This is accomplished by a complementation with the lacZAM15 in SCS-8, resulting in a blue plaque (19) . Plates were examined for the presence ofblue mutant plaques on a background of nonmutant colorless plaques. The ratio of blue plaques to colorless plaques was taken as a measure of the mutagenicity of the compound. Density of plaques was limited to a maximum of 50,000 plaque-forming units per plate (25 cm x 25 cm) to ensure accuracy in detection of plaques with the mutant phenotype.
Calculation of Error Rates. Mutant frequencies are expressed with SEMs at 95% confidence. The SEM is calculated as follows: 2(SD -V-), where n equals the number of mice in a sample. Approximately equal numbers of plaques were analyzed from each mouse in a sample; therefore, the SEM reflects mouse-to-mouse variation in measured mutant frequencies.
Sequence Analysis of Mutants. In vivo excision of the plasmid containing the entire target gene region (including the lacI promoter and lacZ operator) from the A phage was accomplished as described (16) . Recovered plasmid DNA was prepared by a boiling miniprep procedure (20) followed by extraction with HF-silica resin (Strataclean, SCS) (21) . Double-stranded dideoxy sequencing (22) was then performed. DNA sequence is numbered with base 1 being the site of mRNA initiation. All mutations are listed as changes in the coding strand.
RESULTS
Characterization of Transgenic Mice. Three transgenic C57BL/6 offspring were identified by slot blot analysis. Germ-line transmission was confirmed for two lines, and one of these, Al, was selected for further characterization. The copy number of the shuttle vector in the Al lineage was estimated by slot blot analysis to be -30 copies, and Southern blot analysis of BamHI-digested Al genomic DNA indicated that the shuttle vectors integrated as a head-to-tail concatamer at a single locus without detectable rearrangement (data not shown). The Al founder mouse was bred to a nontransgenic C57BL/6 mouse to establish Mendelian inheritance of the A shuttle vector, and 6-to 8-week-old inbred F1 offspring were used in subsequent experiments.
Spontaneous Mutation Rates. Three untreated mice and three treated with phosphate buffer at 10 ml/kg of body weight were used as controls to establish spontaneous background mutation rates for the Al lineage (Table 1) . Approximately 3.5 x 106 plaques were analyzed from genomic DNA prepared from purified male germ cells, yielding a mean spontaneous mutation rate of0.6 x 10-5 + 0.1 X 10-5 (SEM).
To compare this rate to that obtained from somatic tissue, -2.6 x 106 plaques were rescued from spleen genomic DNA isolated from the same mice. The mean spontaneous mutation rate from the spleen was 1.7 x 10-5 + 0.6 x 10-5 (SEM).
Analysis of somatic tissues other than spleen also show Mutagenicity Testing. EtNU. The effects of EtNU were analyzed in spleen and germ-cell genomic DNA (Table 1) . EtNU was administered to three mice each at single doses of 125 and 250 mg/kg of body weight. Analysis of male germ cells showed dose-dependent inductions of =2-fold and -5-fold, respectively, for each dose of EtNU. In addition to the above dosing, three mice were treated with five daily doses of 50 mg of EtNU per kg of body weight and analyzed for mutations in the spleen. An approximate 2-fold, 5-fold, and 8-fold induction, respectively, was seen for each dose level tested.
CP. CP was administered to three mice at 20 mg/kg ofbody weight and to three mice at 100 mg/kg ofbody weight. Spleen genomic DNA was isolated from the treated animals to examine mutagenic effects in this tissue. No induction over background was seen for the low dose of CP, whereas a 2.4-fold induction was observed for the 100 mg/kg dose ( Twenty-one spontaneous mutants were selected from clones rescued from several tissues (ovary, testis, spleen, lung, brain, and liver) for sequence analysis. The types of mutations identified from analysis of these mutants are listed in Table 2 (summarized in Table 5 ). Base substitutions throughout the gene comprise a majority (16/21 or 76%) of the spontaneous mutations. Of these base substitutions, transitions make up 9/16 or 56%, whereas transversions comprise (25, 26) . Our analysis of germ-cell mutations also identified 7 of 13 base substitutions (54%) as occurring at G or C residues. In comparison to the small amount of existing germ-cell sequence data for EtNU, six specific locus mutations have been characterized, and each of them has involved A or T residues (27) (28) (29) .
(ii) B[a]P. Eleven mutants were selected from analysis of spleen tissue [ Table 4 (summarized in Table 5 )]. The most prevalent type of mutations (7/11 or 64%) in this case were also base substitutions, whereas 4 deletion mutants were identified (36%). Of the base substitutions, all were transversions (7 of 7), consistent with previous data for the sequence specificity of B[a]P mutations in lacI, where transversions were predominantly found (30) . In addition, 9 of 11 mutations (82%) involved guanines or cytosines. This is in agreement with the mechanism of B[a]P mutagenesis, where the active metabolite of B[a]P, BPDE, is known to bind principally to the exocyclic amino group of guanine (31) .
DISCUSSION
We have used a A/lacI mutagenesis system in transgenic mice to identify and characterize spontaneous and induced mutations resulting from mouse exposure to EtNU, B[a]P, and CP. The system allows for easy characterization of mutation events calorimetrically and for generation of rapid sequence data to correlate with existing data on the well-studied lacd gene.
Spontaneous background mutant rates in the germ line showed an approximate 3-fold lower rate than obtained with somatic tissue (spleen). Such a difference in background rates was identified by us previously (6) , although in that study, whole testis had been analyzed, not purified germ cells. Although the observation of a lower mutation rate in germ cells is teleologically satisfying for the preservation of heritable genetic integrity, the reason for this difference is not known. Variation in the number of cell divisions required in the germ line and spleen lineage to produce a mature cell, as well as the relative amounts of each precursor cell type present at a given time, may contribute to this difference. Differences in the types of and capacities of repair pathways could also account for the variation between germ-cell and spleen background rates. The presence of a mutagen barrier in the testis, possibly the Sertoli cell layer of the seminiferous tubules (32) , may provide a protection against the effects of weak mutagens in food or drinking water. Whatever the mechanism or combination of mechanisms, it remains to be determined whether these differences will result in altered 86 The data presented in Tables 2-4 This may be due in part to the increased sensitivity of lacI to mutation detection as well as the known tolerance of lacZ for base substitutions in the amino terminus. In addition, administration of EtNU to mice using the lacI system resulted in substantially similar induction rates (6) . Induction of mutations due to EtNU treatment in these experiments is significantly lower than specific locus data for EtNU reported by Hitotsumachi et al. (33) . However, in experiments described here, animals were sacrificed only 3 days following completion of dosing, whereas in the specific locus experiments the animals were maintained for a period of 12-14 weeks following completion of treatment before mating to identify specific locus mutations. Recent experiments using similar alkylating agents in the lacI transgenic mouse system indicate that increased waiting time following dosing results in significantly higher induction rates than presented here for EtNU (G.S.P., S.W.K., and J.M.S., unpublished data). This time difference may allow for increased cell proliferation and DNA replication to fix adducts as mutations. Experiments are necessary to analyze EtNU mutagenesis after a prolonged waiting period following dose completion for a more relevant comparison.
B[a]P administration resulted in the most significant induction levels obtained in this study (11-fold) . This increased response is in accordance with the strong effects observed in in vitro assays using BPDE, the mutagenic B[a]P metabolite (34) . Although mutant induction in the spleen of CP-treated animals was lower relative to the other substances tested, it may be advantageous to examine tissues other than spleen that may be more greatly affected by CP.
Sequence analysis of spontaneous mutations revealed substantially different classes of mutations from that observed in other systems using lac. Although we detected only a single spontaneous insertion at the repeated tetramer site in lacI (bases 620-632), this site accounts for up to 70% of all spontaneous mutations within the lacI gene studied in E. coli (2, 23) . This result suggests that the mutations identified by the A shuttle system in combination with SOS-deficient E. coli strains occurred in the animal.
Our analysis of EtNU mutations induced in germ cells and spleen identified G-C-A-T transitions that have been shown to be the most prevalent EtNU-induced mutations in other assays using lacI in E. coli; however, they comprised only 33% of total mutations observed for EtNU treatment in this eukaryotic system. Nevertheless, our results correlate well with EtNU-induced base substitutions detected in plasmid Additional sequence data are required to identify possible differences in mutation spectra as a function of compound as well as tissue type. This type of analysis may lead to a mechanistic understanding of the mutagenic action of a compound in whole animals. Future use of the lacd target in a transgenic mouse system will build on the valuable existing in vitro data base, with the added advantage of allowing correlation of the in vivo effects on mutation spectra. This system should also predict detailed analysis of tissue-specific mutational analysis, including rapid assessment of germ-line risk.
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